Clinical Trials تتوفر أدناه التجارب السريرية الحالية.119 الدراسات في Neurology and Neurosurgery (الدراسات المفتوحة فقط). تصفية قائمة الدراسات هذه حسب الموقع، والحالة والمزيد. Gemini Study To Evaluate The Integration Of Cancer Genetic Testing Into A Cancer Clinical Practice At Mayo Clinic At Arizona Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ethnic populations seeking care at Mayo Clinic cancer clinics. A Study of the Brain & Body Donation Program Scottsdale/Phoenix, Ariz. The purpose of this study is to study the structure and biochemistry of the brain and/or bodily fluid and tissue after death. Comparison of specimens from normal and diseased individuals provide essential clues that lead to a greater understanding of the diseased state which, in turn, will lead to new ideas for therapy. Collection of Discarded Cerebrospinal Fluid for Research Purposes Rochester, Minn. The purpose of this study is to collect and store cerebrospinal fluid (CSF)from patients with normal CSF. This stored CSF will be used in the future as a culture media to better understand how therapeutic cells delivered into the CSF will behave. Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing’s Disease Rochester, Minn. The purpose of this study is to combine recent advances in ultrasound imaging, specifically an endonasal transducer array and contrast enhanced ultrasound, to offer an intraoperative image-guided solution for lesion-specific surgical resection to impact clinical outcome. Pituitary tumor registry Rochester, Minn. The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic information and surgical outcomes which may include human specimens and associated genomewide expression data. Long Term Clinical Outcomes of Devic’s Disease Rochester, Minn., Jacksonville, Fla. Aims, purpose, or objectives: To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by International Panel for Neuromyelitis Optica Diagnosis (IPND) To described the long term outcomes of a cohort of patients with a diagnosis of NMOSD To identify demographic, clinical and radiologic factors associated with long terms outcomes of NMOSD To determine if patients who are diagnosed with the revised 2015 IPND criteria, in particular those who do not satisfy previous criteria, are ultimately diagnosed with conditions other than NMOSD. To identify treatment effects and complications in this cohort of patients Stem Cells from Skin Fibroblasts in Patients with Hereditary Peripheral Neuropathy Rochester, Minn. The purpose of this research is to develop stem cells from cells within patients’ skin in order to better understand peripheral neuropathy and help develop treatments. A Study to Analyze Intracerebral Hemorrhage Hematoma Jacksonville, Fla. The purpose of this study is to to take the usual waste material from the removal of hematoma and apply an array of -Omics approaches (including for example genomics, transcriptomics, lipidomics, proteomics, and metabolomics) to identify biomarkers that assess prognosis and identify key therapeutic targets. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders Jacksonville, Fla. The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson’s disease (PD), Parkinson’s disease dementia and dementia with Lewy bodies (PDD/DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), cortico-basal degeneration (CBD), and other even rarer forms of neurodegeneration. Validation Of Early Prognostic Data For Recovery Outcome After Stroke For Future, Higher Yield Trials Rochester, Minn. VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window. التصفّح دراسات سريرية السابقالصفحة السابقة توجّه للصفحة 88 توجّه للصفحة 99 توجّه للصفحة 1010 توجّه للصفحة 1111 توجّه للصفحة 1212 التاليالصفحة التالية المتخصصون في المجالات الطبية Neurology & Neurosurgery clinical-trials